Prognostic significance of age related genes in patients with lower grade glioma.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

1. Health-related quality of life outcomes of surgery for diffuse glioma: A systematic review and pooled analysis.Neuro-oncology practice · 2026
   Review
2. Integrated Multiomics Analysis and Mendelian Randomization Identify SIRT1 as a Pivotal Aging-Associated Gene in Meningioma.IUBMB life · 2025
   Article
3. Prognostic value of metal-based ferroptosis and cuproptosis genes and score in lower grade gliomas.Frontiers in immunology · 2025
   Article
4. Glial-Cell-Line-Derived Neurotrophic Factor Promotes Glioblastoma Cell Migration and Invasion via the SMAD2/3-SERPINE1-Signaling Axis.International journal of molecular sciences · 2024
   Article
5. A nomogram with Ki-67 in the prediction of postoperative recurrence and death for glioma.Scientific reports · 2024
   Article
6. Prognostic relevance and validation of ARPC1A in the progression of low-grade glioma.Aging · 2024
   Article
7. Expressions of the satellite repeat HSAT5 and transposable elements are implicated in disease progression and survival in glioma.Turkish journal of biology = Turk biyoloji dergisi · 2024
   Article
8. Risk prediction and treatment assessment in glioma patients using SEER database: a prospective observational study.BMJ open · 2023
   Observational
9. The emerging role of Arid5a in cancer: A new target for tumors.Genes & diseases · 2023
   Review
10. Co-amplified with PDGFRA, IGFBP7 is a prognostic biomarker correlated with the immune infiltrations of glioma.Cancer medicine · 2023
    Article
11. Aberrant methylation of Serpine1 mediates lung injury in neonatal mice prenatally exposed to intrauterine inflammation.Cell & bioscience · 2022
    Article
12. Differences in the Expression Patterns ofCancers · 2022
    Article
13. Identification and Validation of a Gene Signature for Lower-Grade Gliomas Based on Pyroptosis-Related Genes to Predict Survival and Response to Immune Checkpoint Inhibitors.Journal of healthcare engineering · 2022
    Article
14. Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma.BMC pediatrics · 2021
    Article
15. Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis.Bioscience reports · 2021
    Article
16. Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients.Frontiers in neurology · 2021
    Article
17. Recent Advances in the Role of Arid5a in Immune Diseases and Cancer.Frontiers in immunology · 2021
    Review
18. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.BioMed research international · 2020
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

5 authors at 3 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as